2658-6533Research Results in Biomedicine2658-653310.18413/2658-6533-2020-6-3-0-32105Genetics<strong>Association of L432V (rs1056836) polymorphism of the <em>CYP1B1 </em>gene with the increased risk of colorectal cancer in the population of Central Russia</strong><strong>Association of L432V (rs1056836) polymorphism of the <em>CYP1B1 </em>gene with the increased risk of colorectal cancer in the population of Central Russia</strong>MoskalevAlexander S.MoskalevAlexander S.moskalev-46@yandex.ru20206300

Background:&nbsp;Colon malignancies are one of the most common worldwide. Different pro-carcinogenic agents such as polycyclic aromatic hydrocarbons (PAH) and heterocyclic aromatic amines can potentially play a key role in the malignant transformation of cells by interacting with DNA. The enzyme of the 1st phase of xenobiotic biotransformation CYP1B1 is involved in the metabolic activation of various carcinogens. The aim of the study:&nbsp;The aim of our study was to investigate the association between common SNP rs1056836 CYP1B1 and the risk of CRC in the population of Central Russia. Materials and methods:&nbsp;A total of 256 patients with colorectal cancer (134 males, 122 females) and 608 age- and sex-matched healthy controls (279 males, 329 females) were recruited for the study. Genotyping of single nucleotide polymorphism L432V (rs1056836) CYP1B1 were done using Taq-Man-based assays. Results:&nbsp;Single nucleotide polymorphism rs1056836 (substitution L432V) CYP1B1 was associated with the increased risk of colorectal cancer in the population of Central Russia after adjustment for gender, age: ORadj=1.34; 95%CIadj=1.08&ndash;1.66; Padj=0.01. Bioinformatic analysis showed the spectrum of transcription factors binding with low-risk C (L) allele are involved in regulation of differentiation of CD8+ alpha-beta T cells (FDR=7.57&times;10-3) and activation of CD8+ of alpha-beta T cells (P=3.47&times;10-5, FDR=2.63&times;10-2). Transcription factors binding with high-risk V allele are not involved in T cell dependent mechanisms of cancer immunoediting. Conclusion:&nbsp;Thus, SNP rs1056836 CYP1B1 is associated with the increased risk of colorectal cancer in the population from Central Russia. &nbsp;

Background:&nbsp;Colon malignancies are one of the most common worldwide. Different pro-carcinogenic agents such as polycyclic aromatic hydrocarbons (PAH) and heterocyclic aromatic amines can potentially play a key role in the malignant transformation of cells by interacting with DNA. The enzyme of the 1st phase of xenobiotic biotransformation CYP1B1 is involved in the metabolic activation of various carcinogens. The aim of the study:&nbsp;The aim of our study was to investigate the association between common SNP rs1056836 CYP1B1 and the risk of CRC in the population of Central Russia. Materials and methods:&nbsp;A total of 256 patients with colorectal cancer (134 males, 122 females) and 608 age- and sex-matched healthy controls (279 males, 329 females) were recruited for the study. Genotyping of single nucleotide polymorphism L432V (rs1056836) CYP1B1 were done using Taq-Man-based assays. Results:&nbsp;Single nucleotide polymorphism rs1056836 (substitution L432V) CYP1B1 was associated with the increased risk of colorectal cancer in the population of Central Russia after adjustment for gender, age: ORadj=1.34; 95%CIadj=1.08&ndash;1.66; Padj=0.01. Bioinformatic analysis showed the spectrum of transcription factors binding with low-risk C (L) allele are involved in regulation of differentiation of CD8+ alpha-beta T cells (FDR=7.57&times;10-3) and activation of CD8+ of alpha-beta T cells (P=3.47&times;10-5, FDR=2.63&times;10-2). Transcription factors binding with high-risk V allele are not involved in T cell dependent mechanisms of cancer immunoediting. Conclusion:&nbsp;Thus, SNP rs1056836 CYP1B1 is associated with the increased risk of colorectal cancer in the population from Central Russia. &nbsp;

colorectal cancerSNPbiotransformation of xenobioticsrs1056836CYP1B1colorectal cancerSNPbiotransformation of xenobioticsrs1056836CYP1B1Список литературыFavoriti P, Carbone G, Greco M, et al. &nbsp;Worldwide burden of colorectal cancer: a review. Updates in Surgery. 2016;68(1):7-11. DOI: https://doi.org/10.1007/s13304-016-0359-yPetrash EA. Social identity disorders in patients with colorectal cancer (colostomy). Kursk Scientific and Practical Bulletin &quot;Man and His Health&quot;. 2015;(2):120-125. Russian.Jeon J, Du M, Schoen RE, et al. Determining risk of colorectal cancer and starting age of screening based on lifestyle, environmental, and genetic factors. Gastroenterology. 2018;154(8):2152‐2164. DOI: http://dx.doi.org/10.1053/j.gastro.2018.02.021G&oacute;ngora VM, Matthes KL, Casta&ntilde;o PR, et al. Dietary heterocyclic amine intake and colorectal adenoma risk: A systematic review and meta-analysis. Cancer Epidemiology Biomarkers and Prevention. 2019;28(1):99-109. DOI: 10.1158/1055-9965.EPI-17-1017Ewa B, Danuta M&Scaron;. Polycyclic aromatic hydrocarbons and PAH-related DNA adducts. . 2017;58(3):321‐330. DOI: https://doi.org/10.1007/s13353-016-0380-3Moskalev AS, Soldatov VO, Vdovina IN, et al. The relationship between polymorphism I462V of the CYP1A1 gene and -9-154C&gt;A of the CYP1A2 gene and colorectal cancer risk in the population of Central Russia. Medical Genetics. 2017;16(3):41-45. Russian.Moskalev AS, Barysheva EM, Soldatov VO, et al. Association of C3435T (rs1045642) polymorphism of the MDR1 gene with the increased risk of colorectal cancer in Russian females from Central Russia. Russian Journal of Genetics. 2019;55(12):1514-1519. DOI: 10.1134/S1022795419120093Figueroa C, G&aacute;lvez-Cancino F, Oyarce C, et al. Inhibition of dopamine receptor D3 signaling in dendritic cells increases antigen cross-presentation to CD8+ T-cells favoring anti-tumor immunity. Journal of Neuroimmunology. 2017;303:99‐107. DOI: http://dx.doi.org/10.1016/j.jneuroim.2016.12.014Zander R, Schauder D, Xin G, et al. &nbsp;CD4+ T cell help is required for the formation of a cytolytic CD8+ T cell subset that protects against chronic infection and cancer. Immunity. 2019;51(6):1028‐1042.e4. DOI: https://doi.org/10.1016/j.immuni.2019.10.009Murray GI, Melvin WT, Greenlee WF, et al. Regulation, function, and tissue-specific expression of cytochrome P450 CYP1B1. Annual Review of Pharmacology and Toxicology. 2001;41:297‐316. DOI: https://doi.org/10.1146/annurev.pharmtox.41.1.297Hanna IH, Dawling S, Roodi N, et al.Cytochrome P450 1B1 (CYP1B1) pharmacogenetics: association of polymorphisms with functional differences in estrogen hydroxylation activity.Hlavata I, Vrana D, Smerhovsky Z, et al. Association between exposure-relevant polymorphisms in CYP1B1, EPHX1, NQO1, GSTM1, GSTP1 and GSTT1 and risk of colorectal cancer in a Czech population. Oncology Reports. 2010;24(5):1347‐1353. DOI: https://doi.org/10.3892/or_00000992Landi S, Gemignani F, Moreno V, et al. Colorectal Cancer Study Group. A comprehensive analysis of phase I and phase II metabolism gene polymorphisms and risk of colorectal cancer. Pharmacogenetics and Genomics. 2005;15(8):535‐546. DOI: 10.1097/01.fpc.0000165904.48994.3dXie Y, Liu GQ, Miao XY, et al. CYP1B1 Leu432Val polymorphism and colorectal cancer risk among Caucasians: a meta-analysis. Tumor Biology. 2012;33(3):809‐816. DOI: https://doi.org/10.1007/s13277-011-0298-7He XF, Wei J, Liu ZZ, et al. Association between CYP1A2 and CYP1B1 polymorphisms and colorectal cancer risk: a meta-analysis. PLoS One. 2014;9(8):e100487. DOI: https://doi.org/10.1371/journal.pone.0100487Bethke L, Webb E, Sellick G, et al. Polymorphisms in the cytochrome P450 genes CYP1A2, CYP1B1, CYP3A4, CYP3A5, CYP11A1, CYP17A1, CYP19A1 and colorectal cancer risk. BMC Cancer. 2007;7:123. DOI: https://doi.org/10.1186/1471-2407-7-123Laroche-Clary A, Le Morvan V, Yamori T, et al. Cytochrome P450 1B1 gene polymorphisms as predictors of anticancer drug activity: studies with in vitro models. Molecular Cancer Therapeutics. 2010;9(12):3315‐3321. DOI: 10.1158/1535-7163.MCT-10-0673&nbsp;